Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Endocrine surgery

Treatment & Surgery: What to Expect

At a Glance

For a suspected follicular thyroid adenoma, diagnostic lobectomy removes the affected half of the thyroid so the entire nodule can be examined. Active surveillance may be reasonable for selected low-risk nodules, while total thyroidectomy is reserved for specific situations.

When a biopsy result comes back as “indeterminate”—such as Bethesda III or Bethesda IV—the primary goal of treatment is to determine the best next step for your specific situation [1]. Because tests like ultrasound and biopsy cannot see through the nodule’s capsule, surgery is often recommended to prove whether a nodule is a benign follicular thyroid adenoma (FTA) rather than cancer [2].

The Gold Standard: Diagnostic Lobectomy

The standard surgical approach for a suspected follicular adenoma is a lobectomy (also called a hemithyroidectomy) [3]. In this procedure, the surgeon removes only the half of the thyroid gland containing the nodule.

A lobectomy is considered “diagnostic” because its main purpose is to provide the pathologist with the entire nodule to examine [1]. If the final pathology report confirms the nodule is an FTA, the surgery is complete, and no further treatment is usually needed [4].

Why Not Remove the Whole Thyroid?

You may wonder why surgeons don’t simply remove the entire gland (total thyroidectomy) to be “safe.” For most patients with a suspected FTA, removing the whole gland is avoided for several important reasons:

  • Preserving Hormone Function: Many patients who keep half their thyroid can still produce enough hormone to avoid taking daily medication, though roughly 30% will eventually need levothyroxine [5][6].
  • Lower Risk to Vocal Cords: The recurrent laryngeal nerve, which controls your voice, runs behind the thyroid. Removing only half the gland avoids the possibility of bilateral nerve injury [7].
  • Protecting Calcium Levels: Your parathyroid glands (four tiny glands that regulate calcium) are located on the back of the thyroid. Total thyroidectomy substantially increases the risk of damaging these glands, which can lead to lifelong low calcium levels (hypoparathyroidism) [3][7].

Total thyroidectomy is a shared decision. Total removal might be considered if there are highly suspicious nodules on both sides, significant compressive symptoms, or strong patient preference, but even some confirmed low-risk cancers are appropriately treated with lobectomy [1][8].

Understanding the Risks

Every surgery has risks, but a lobectomy is generally a very safe procedure with a short recovery time.

  1. Hypothyroidism: While the goal is to preserve thyroid function, your remaining lobe might not be able to keep up with your body’s demands. Approximately 20% to 40% of lobectomy patients eventually need levothyroxine (thyroid hormone replacement) [6][9].
  2. Voice Changes: Temporary hoarseness is common due to irritation from the breathing tube or the surgery itself. Permanent voice changes from unilateral nerve damage occur in about 1% to 2% of cases [7]. Surgeons often use intraoperative nerve monitoring as an adjunct tool to help protect the nerve [10].
  3. Low Calcium: This is rare in a lobectomy because the parathyroid glands on the untouched side usually continue to function normally [3].
  4. Completion Surgery: If the final pathology report unexpectedly finds a higher-risk cancer, you may discuss a second surgery to remove the remaining half of the thyroid. This is not expected for a confirmed benign FTA, but it is a possibility when going into diagnostic surgery for an indeterminate nodule [11].

The Option of Active Surveillance

Before surgery, in some carefully selected cases, you and your doctor may choose active surveillance (monitoring) instead of an immediate operation. This might be considered if:

  • The nodule has low-risk ultrasound findings [12].
  • Molecular testing (like Afirma or ThyroSeq) has come back with a reassuring, “benign” result, lowering the estimated risk [13][14].
  • You have significant surgical risks or a strong preference to avoid surgery [15].

Surveillance involves regular ultrasounds to ensure the nodule is not growing or changing [15]. If significant growth is detected, it triggers a reassessment and potentially a recommendation for surgery.

Preparing for Your Consultation

When meeting with a surgeon, it is important to ask about their experience. Research shows that surgeons who perform a high volume of thyroid surgeries (some definitions use 25 to 50 or more annually) generally have lower complication rates and shorter hospital stays [16][17]. Do not hesitate to ask your surgeon for their specific complication rates and whether they use tools like nerve monitoring to help protect your voice during the procedure.

Common questions in this guide

What is a diagnostic lobectomy for a follicular thyroid adenoma?
A diagnostic lobectomy, also called a hemithyroidectomy, removes the half of the thyroid containing the nodule. It allows a pathologist to examine the entire nodule and determine whether it is a benign adenoma or cancer. If the final result confirms a benign follicular thyroid adenoma, further treatment is usually not needed.
Why is total thyroidectomy not always recommended for an indeterminate thyroid nodule?
Removing only the affected half of the thyroid may preserve natural hormone production and lowers the risk of injury to both voice nerves and all of the parathyroid glands. Many people avoid lifelong thyroid medication after lobectomy, although some eventually need levothyroxine. Total thyroidectomy may still be considered when both sides are concerning, symptoms are significant, or the patient strongly prefers it.
What are the main risks of thyroid lobectomy?
Possible risks include an underactive thyroid requiring levothyroxine, temporary hoarseness, and uncommon permanent voice changes. Low calcium is rare after lobectomy because the parathyroid glands on the other side usually remain intact. If the final pathology unexpectedly shows a higher-risk cancer, a second operation to remove the remaining thyroid may be discussed.
Can I monitor an indeterminate follicular thyroid nodule instead of having surgery?
In selected cases, active surveillance may be considered when ultrasound findings are low risk, molecular testing is reassuring, or surgery carries substantial risk. Surveillance usually involves regular ultrasounds to check for growth or other changes. Significant growth or a change in risk may lead to reassessment and surgery.
How likely am I to need thyroid hormone after a lobectomy?
About 20% to 40% of people who have a thyroid lobectomy eventually need levothyroxine because the remaining lobe does not make enough hormone. Your risk depends on factors such as the function of the remaining thyroid and your underlying thyroid health, so follow-up blood tests are important.
How can I choose an experienced thyroid surgeon?
Ask how many thyroid operations the surgeon performs each year and about their rates of permanent voice nerve injury and permanent low calcium. Higher-volume thyroid surgeons generally have fewer complications and shorter hospital stays. You can also ask whether intraoperative nerve monitoring is used as an additional tool to help protect your voice.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many thyroid surgeries do you perform each year? (Studies suggest high-volume surgeons have fewer complications.)
  2. 2.What are your personal rates for permanent nerve damage (hoarseness) and permanent low calcium (hypoparathyroidism)?
  3. 3.Do you use intraoperative nerve monitoring as an adjunct to help protect my vocal cords during the procedure?
  4. 4.Based on my specific ultrasound, biopsy, and molecular testing, what are the pros and cons of lobectomy versus active surveillance?
  5. 5.If my final pathology unexpectedly shows cancer, how likely is it that I would need a second surgery ('completion thyroidectomy')?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Utility of mutational analysis for risk stratification of indeterminate thyroid nodules in a real-world setting.

    Torrecillas V, Sharma A, Neuberger K, Abraham D

    Clinical endocrinology 2022; (96(4)):637-645 doi:10.1111/cen.14601.

    PMID: 34605038
  2. 2

    RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists.

    Hernandez-Prera JC, Wenig BM

    Endocrine pathology 2024; (35(3)):167-184 doi:10.1007/s12022-024-09812-5.

    PMID: 38888731
  3. 3

    Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series.

    Conzo G, Avenia N, Ansaldo GL, et al.

    Endocrine 2017; (55(2)):530-538 doi:10.1007/s12020-016-0953-2.

    PMID: 27075721
  4. 4

    NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

    Haddad RI, Nasr C, Bischoff L, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2018; (16(12)):1429-1440 doi:10.6004/jnccn.2018.0089.

    PMID: 30545990
  5. 5

    FACTORS INFLUENCING THE SUCCESSFUL MAINTENANCE OF EUTHYROIDISM AFTER LOBECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A SINGLE-CENTER STUDY.

    Ha TK, Kim DW, Park HK, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019; (25(10)):1035-1040 doi:10.4158/EP-2019-0153.

    PMID: 31241363
  6. 6

    Current surgical treatment of intermediate risk differentiated thyroid cancer: a systematic review.

    Guo MY, Wiseman JJ, Wiseman SM

    Expert review of anticancer therapy 2021; (21(2)):205-220 doi:10.1080/14737140.2021.1850280.

    PMID: 33176520
  7. 7

    Risks Associated With Extent of Surgical Management for Benign, Non-Toxic Goiter.

    Brady JS, Konuthula N, Lam A, et al.

    Laryngoscope investigative otolaryngology 2025; (10(4)):e70214 doi:10.1002/lio2.70214.

    PMID: 41158116
  8. 8

    Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category IV (FN/SFN).

    Kuru B, Kefeli M

    Diagnostic cytopathology 2018; (46(6)):489-494 doi:10.1002/dc.23923.

    PMID: 29524316
  9. 9

    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.

    Hu QL, Chen L, Kuo EJ, et al.

    Surgery 2024; (175(4)):1029-1033 doi:10.1016/j.surg.2023.11.016.

    PMID: 38097483
  10. 10

    Thyroid and parathyroid surgeon case volume influences patient outcomes: A systematic review.

    Bedi HK, Jedrzejko N, Nguyen A, et al.

    Surgical oncology 2021; (38()):101550 doi:10.1016/j.suronc.2021.101550.

    PMID: 33915486
  11. 11

    From Lobectomy to Completion Thyroidectomy: A Cohort Study and Systematic Review.

    Tessler I, Yamin T, Caracucli L, et al.

    Clinical endocrinology 2026; (105(1)):108-115 doi:10.1111/cen.70130.

    PMID: 41866695
  12. 12

    Cytology-Radiology Correlation Series: Thyroid cytopathology.

    Jug R, Foo WC, Wildman-Tobriner B, Jiang XS

    Cancer cytopathology 2025; (133(8)):e70028 doi:10.1002/cncy.70028.

    PMID: 40699188
  13. 13

    Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier.

    Ahmadi S, Kotwal A, Bikas A, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(12)):e2231-e2239 doi:10.1210/clinem/dgae112.

    PMID: 38415829
  14. 14

    Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.

    Steward DL, Carty SE, Sippel RS, et al.

    JAMA oncology 2019; (5(2)):204-212 doi:10.1001/jamaoncol.2018.4616.

    PMID: 30419129
  15. 15

    How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?

    Steinmetz D, Kim M, Choi JH, et al.

    World journal of surgery 2022; (46(12)):3043-3050 doi:10.1007/s00268-022-06744-1.

    PMID: 36167834
  16. 16

    Volume, outcomes, and quality standards in thyroid surgery: an evidence-based analysis-European Society of Endocrine Surgeons (ESES) positional statement.

    Lorenz K, Raffaeli M, Barczyński M, et al.

    Langenbeck's archives of surgery 2020; (405(4)):401-425 doi:10.1007/s00423-020-01907-x.

    PMID: 32524467
  17. 17

    Disparities in utilization of high-volume thyroid surgeons for Graves disease: a statewide analysis.

    Xie S, Jensen CB, Sinha A, et al.

    Journal of the Endocrine Society 2026; (10(5)):bvag051 doi:10.1210/jendso/bvag051.

    PMID: 42005303

This page is for informational purposes only and does not constitute medical advice. Your thyroid surgeon and care team can advise whether lobectomy, active surveillance, or another option fits your results and overall health.

Get notified when new evidence is published on follicular thyroid adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.